Aeroplysinin-1 is primarily studied for its potential in medical and pharmaceutical applications due to its bioactive properties. It has shown promising antimicrobial activity, making it a candidate for developing new antibiotics, particularly against drug-resistant bacterial strains. Additionally, it exhibits anti-inflammatory effects, which could be useful in treating inflammatory diseases. Research also highlights its potential in cancer therapy, as it has demonstrated cytotoxic effects on certain cancer cell lines, suggesting its role in inhibiting tumor growth. Further studies are ongoing to explore its full therapeutic potential and mechanisms of action.